Cardiac troponin I antibodies induce cardiomyocyte damage and alter cell morphology

Circulating heart-reactive autoantibodies (aAbs) detected in a variety of heart diseases (e.g., myocarditis, dilated cardiomyopathy, and myocardial infarction) have been associated with the progression of heart failure and a poor prognosis. However, the underlying mechanisms remain largely unknown....

Full description

Saved in:
Bibliographic Details
Main Authors: Furkel, Jennifer (Author) , Zirkenbach, Vanessa A. (Author) , Knoll, Maximilian (Author) , Öttl, Renate (Author) , Rein, Katrin (Author) , Abdollahi, Amir (Author) , Frey, Norbert (Author) , Konstandin, Mathias (Author) , Kaya, Ziya (Author)
Format: Article (Journal)
Language:English
Published: 14 October 2025
In: International journal of molecular sciences
Year: 2025, Volume: 26, Issue: 20, Pages: 1-17
ISSN:1422-0067
DOI:10.3390/ijms262010005
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/ijms262010005
Verlag, kostenfrei, Volltext: https://www.mdpi.com/1422-0067/26/20/10005
Get full text
Author Notes:Jennifer Furkel, Vanessa A. Zirkenbach, Maximilian Knoll, Renate Öttl, Katrin Rein, Amir Abdollahi, Norbert Frey, Mathias H. Konstandin and Ziya Kaya
Description
Summary:Circulating heart-reactive autoantibodies (aAbs) detected in a variety of heart diseases (e.g., myocarditis, dilated cardiomyopathy, and myocardial infarction) have been associated with the progression of heart failure and a poor prognosis. However, the underlying mechanisms remain largely unknown. We investigated the effects of murine plasma containing aAbs against cardiac troponin I (cTnI) on neonatal rat cardiomyocytes (NRCMs). An autoimmune response to cTnI in A/J mice was induced, and anti-cTnI-aAbs were quantified. After 21 days, cardiac function, inflammation, fibrosis, and apoptosis were evaluated. In complementary in vitro liquid biopsy experiments, NRCMs were incubated with murine plasma containing high anti-cTnI-aAb levels or corresponding controls. Morphological phenotyping was performed using the C-MORE fluorescent image-based analysis workflow. Immunization with cTnI resulted in high anti-cTnI-aAb production, followed by myocardial inflammation, fibrosis, and impaired ejection fraction. NRCMs exposed to anti-cTnI-aAb-containing plasma showed reduced cell size, altered shape and radius, and elevated rate of dead cells in cell cycle analysis (p < 0.01, for 20% plasma). Together, these findings suggest a direct interaction of anti-cTnI-aAbs on cardiomyocytes, likely promoting adverse myocardial remodeling in vivo.
Item Description:Veröffentlicht: 14. Oktober 2025
Gesehen am 04.12.2025
Physical Description:Online Resource
ISSN:1422-0067
DOI:10.3390/ijms262010005